XMAB

Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for therapeutic use for the treatment of cancer and proliferative cell diseases

Pharmaceutical and biological product development consultation relating to monoclonal antibodies; and pharmaceutical and biological product development for others relating to monoclonal antibodies